Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Profound Medical Corp. (PROF) Stock · BUY · RECOVERY | LOPJLB

Profound Medical Corp. (PROF)

Healthcare · Medical - Devices · NASDAQ · CA

$6.91+21.65%Close

BUYRECOVERY · day 4

PROF▲ BUY

$6.91+21.65%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $251M
Beta: 0.53
P/E (TTM): -6.28

Short % float: 5.41%
Days to cover: 12.3
SI change: -3.0%

1W: +18.12%
1M: +1.62%

vs SPY 1W: +16.56%
vs SPY 1M: -0.15%

Industry peers

FMP comparable companies · ranked by market cap

AVRSELLAnteris Technologies Global Corp.$685MCRISISQ 18$7.05-2.79%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and…

Employees: 162
Headquarters: CA
Founded: 2019
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares out: 36.3M
Float: 95.9%

profoundmedical.com ↗

Key executives

Arun Swarup Menawat — Chairman of the Board & Chief Executive Officer

Mathieu Burtnyk — President

Rashed Dewan — Chief Financial Officer

SEC filings

EDGAR · CIK 16288080 · PROF

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish685.7%

Neutral114.3%

Bearish00.0%

L $11.00Avg $11.00H $11.00

Target$11.00+59.19%

Last$6.91

Company news

zacks.com · 6h ago

Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?

globenewswire.com · 7h ago

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

globenewswire.com · 2d ago

Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue

globenewswire.com · 36d ago

Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference

globenewswire.com · 38d ago

Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President

globenewswire.com · 53d ago

Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days'

globenewswire.com · 56d ago

Profound Medical Announces Management Change

globenewswire.com · 57d ago

Profound Medical Launches ‘Let's Huddle', a Global Community Supporting Men Throughout Their Prostate Care Journey

marketbeat.com · 63d ago

Profound Medical Q2 Earnings Call Highlights

zacks.com · 64d ago

Profound Medical (PROF) Q2 Earnings Surpass Estimates

globenewswire.com · 64d ago

Profound Medical Reports Second Quarter 2026 Financial Results

globenewswire.com · 77d ago

Robotic Radical Prostatectomy Comes Up ‘Short' in CAPTAIN Trial

globenewswire.com · 85d ago

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow

globenewswire.com · 86d ago

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

Market news & ticker search · RSS for PROF

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE